Heitner BioInnovation ApS: Financial statements 2025
CVR: 41712937
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Heitner BioInnovation ApS (CVR 41712937) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -454 and a net result of DKK -454 compared with DKK -1,228 the year before. Equity in the 2025 report amounted to DKK 16,959. The solvency ratio was 100%.
- Gross Profit
- DKK -454
- Profit/Loss
- DKK -454
- Equity
- DKK 16,959
- Total Assets
- DKK 16,959
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -454 | -454 | 17K | - |
| 2024 | - | -1K | -1K | 17K | - |
| 2023 | - | -1K | -1K | 19K | - |
| 2022 | - | - | -600 | 20K | - |
Official annual report
How creditworthy is Heitner BioInnovation ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Heitner BioInnovation ApS has published its annual report for 2024. Gross profit came to DKK -1,228, and the net result was DKK -1,228.
About Heitner BioInnovation ApS
Heitner BioInnovation ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Tara Renée Heitner. The company is owned by Tara Renée Heitner. In 2025, the company reported a gross profit of DKK -454 and a net result of DKK -454 compared with DKK -1,228 the year before. Equity in the 2025 report amounted to DKK 16,959.